Michigan Stroke Transitions Trial



Status:Completed
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:January 2016
End Date:November 30, 2017

Use our guide to learn which trials are right for you!

The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program

The Michigan Stroke Transitions Trial (MISTT) is a patient-centered randomized control trial
that aims to improve the experience of stroke patients after they return home. The MISTT
study will test the effect of two complementary interventions against usual care. The two
interventions include: a) Stroke Case Managers (SCMs) who are trained social workers, and b)
an online informational website or portal. The 12 week intervention period begins when the
stroke patient returns home from the hospital or rehab facility. The SCMs will conduct at
least 2 home visits with the patient (one within 3-4 days and one around 30 days) along with
weekly follow-up telephone calls. Supplemental home visits will be used as necessary over the
12 week period. At the first home visit the social workers will conduct a comprehensive
in-home assessment and link patients and caregivers to local resources as necessary. Patients
also assigned to the website will have access to a patient-centered online information and
support resource called the Virtual Stroke Support Portal (VSSP). The investigators
hypothesize that this personalized case management program will reduce patient and caregiver
needs, improve quality of life, and decrease caregiver stress. The MISTT study will enroll
315 acute stroke patients discharged from 3 Michigan hospitals and will be completed by the
end of 2017.

To improve care transitions for acute stroke patients this pragmatic, community-based,
randomized, open clinical trial will test the efficacy of two separate but complementary
interventions against usual care. The parallel group design will compare the following 3
groups:

1. Usual care

2. Stroke Case Manager (SCM): trained social workers who provide home based case management
services

3. SCM services plus access to the Virtual Stroke Support Portal (VSSP) an online
information and support resource.

This patient-level randomized trial will be conducted at 3 Michigan hospitals and will enroll
a total of 315 acute stroke patients (105 per intervention group). Each hospital will enroll
cases over an 18 month period. Randomization will be balanced within each hospital to ensure
that an equal number of patients are assigned to the 3 groups. If the patient identifies a
primary caregivers they will be contacted and enrollment accordingly.

The trial interventions begin once the patient returns home (= Day 1) and end 3 months later
(= Day 90). Outcomes data will be collected by telephone at baseline (= Day 7) and at Day 90.
Subjects who are enrolled but do not go home within 1 month (because they remain in a
rehabilitation or Skilled Nursing Facility) will be dropped and replaced by new patients. Two
primary patient-level outcome measures include the Patient Activation Measure (PAM), a
measure of self-efficacy, and the PROMIS-10, a global quality of life scale. Two primary
caregiver-level outcome measures include the Bakas Caregiving Outcomes Scale (BCOS) and
depression (PHQ-9).

By adhering to the principles of pragmatic trials, this trial is designed to inform typical
U.S. clinical practice, with outcomes that are directly relevant to patients and caregivers.
Specifically, this trial is designed to answer the practical question of whether the
transitional care experience of stroke patients and caregivers can be improved by social
workers who visit the home, and whether their effectiveness can be enhanced by a
comprehensive patient-centered online resource.

Patient Inclusion Criteria:

- A final confirmed hospital diagnosis of acute stroke (ischemic or hemorrhagic).

- Patient living at home pre-stroke.

- Presence of stroke-related deficits at admission (defined as a National Institute of
Health Stroke Severity score of >=1).

- Presence of at least mild functional limitations at discharge (defined as a modified
Rankin score [mRS] score of >=1), or therapy ordered.

- Discharged directly home (includes patient's residence or that of a family member).

- Discharged to a rehabilitation facility (IRF or SNF) with the expectation of return to
home within 4 weeks.

Patient Exclusion Criteria:

- Patients who live more than 50 miles from the hospital (for reasons related to the
home visits).

- Patients discharged to nursing home, hospice care or LTCH (Long term care hospital).

- Patients who have clinically documented cognitive deficits or stroke-related
impairments including aphasia sufficient to impact the consent process and for whom a
proxy respondent is not available.

- Patients who fail the 6-item cognitive screening (SIS-6) for cognitive impairment
(score <=4) and for whom a proxy respondent is not available

- Patients enrolled in another acute stroke intervention trial that has a significant
impact on the post-acute period (i.e., intensive data collection required of patient
during follow-up).

- Limited life expectancy (< 6 months) or significant medical comorbidity likely to
impact completion of the study (e.g., severe mental illness, drug or alcohol use or
dependence, metastatic cancer).

- Neither the patient nor caregiver speaks English.

Caregiver Inclusion Criteria:

- Age 18 or over.

- Are identified by the stroke patient as the primary caregiver (individual who has
primary responsibility for assisting with the patient's care).

- Speaks English.
We found this trial at
3
sites
Ypsilanti, Michigan 48197
Principal Investigator: Susan Hickenbottom, MD, MS
?
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
Principal Investigator: Lynda D Lisabeth, MPH, PhD
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Lansing, Michigan 48909
Principal Investigator: Anmar Razak, MD
?
mi
from
Lansing, MI
Click here to add this to my saved trials